Duplicate Document
This document appears to be a copy. The original version is:
EFTA Document EFTA01453915Case File
efta-efta01453915DOJ Data Set 10CorrespondenceEFTA Document EFTA01453915
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01453915
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Summary
Ask AI About This Document
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
As of 4/23/14 11:34 pm
Description
Trade Date
Quantity
Current Price
Unit Cost
Market value
Current Total Cost
Unrealized G/L
SANGAMO BIOSCIENCES
5/28/2013
50,000.00
$
14.17
$
8.44
$
708,500.00
422,214.00 $
286,286.00
BIOGEN
2/14/2012
2,095.00
$
300.61 $
119.55
$
629,786.33
250,454.95 $
379,331.38
FOUNDATION MEDICINE
1/13/2014
25,000.00
$
26.74
$
27.51
$
668,500.00
687,663.50 $
(19,163.50)
GILEAD SCIENCES INC
Multiple
8,100.00
$
74.93
$
79.41
$
606,932.19
643,204.00
5
(36,271.81)
ARIAD PHARMACEUTICALS
Multiple
16,535.00
$
7.58
$
17.60
$
125,333.65
290,997.40 $
(165,663.75)
Total Biotech
$
2,739,052.17
$
2,294,533.85
$
444,518.32
PX_LAST
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
CONFIDENTIAL
DB-SDNY-0111771
SDNY_GM_00257955
EFTA01453915
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.